about
Secular trends in colon and rectal cancer relative survival.Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task ForceComparative economic evaluation of data from the ACRIN National CT Colonography Trial with three cancer intervention and surveillance modeling network microsimulations.Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare populationPersonalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits.Development of new non-invasive tests for colorectal cancer screening: the relevance of information on adenoma detection.Optimal colorectal cancer screening in states' low-income, uninsured populations—the case of South Carolina.Cost-Savings to Medicare From Pre-Medicare Colorectal Cancer Screening.A systematic comparison of microsimulation models of colorectal cancer: the role of assumptions about adenoma progression.Radiation-related cancer risks from CT colonography screening: a risk-benefit analysisClarifying differences in natural history between models of screening: the case of colorectal cancerContribution of screening and survival differences to racial disparities in colorectal cancer rates.Stool DNA testing to screen for colorectal cancer in the Medicare population: a cost-effectiveness analysis.Derivation of background mortality by smoking and obesity in cancer simulation models.How should individuals with a false-positive fecal occult blood test for colorectal cancer be managed? A decision analysisValidation of Models Used to Inform Colorectal Cancer Screening Guidelines: Accuracy and Implications.Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force.Is fecal occult blood testing more sensitive for left- versus right-sided colorectal neoplasia? A systematic literature review.Cost Effectiveness of Age-specific Screening Intervals for People With Family Histories of Colorectal Cancer.A restricted look at CRC screening: not considering annual stool testing as an option.Extracolonic findings from CTC: balancing risks and benefits.Models in the development of clinical practice guidelines
P50
Q30558513-330BC3BD-7CA8-4354-8BC2-43A47F4CB261Q33859917-B7BA14BA-04A7-49DC-A758-6C7B20C97F26Q33981053-FC05EE1E-5BC4-41B7-B121-F4791CD522E1Q34071763-971FDDAC-4F3B-4C48-8BAD-631835785542Q34159375-82EEB7CA-5E67-4266-A149-3863C1D9F980Q35417403-2E6F5E58-34C7-43F5-98FE-A2AC225AD7C0Q35670730-E24AA54D-F081-4A7F-9C28-E234046B6C89Q35742634-4EF854BF-5F98-46D7-B544-66E89591170DQ36180124-1CBE8175-D753-4642-9117-F9408BFF780CQ36314835-3DA501E8-4FDE-4913-9330-B628400AA57CQ36493426-E253C054-A0B6-4F9B-8CD2-7181324E9C17Q36493434-74CCA44B-BFC5-4E25-A51B-04F021BEE188Q36627490-9ABDDC6A-7F96-48BD-A0BA-94C4539C4ED3Q36873349-782D5C21-2A47-48F6-AC3F-AF8C56059E99Q36957761-AF4F7A36-B815-4642-900E-D75FC03851CDQ37228194-1707A994-A968-4D8F-9F60-E405FAAABFB5Q37318617-AD3AC993-EA6B-4630-A830-4962893D4CA9Q37899886-FEABE712-6A12-4DAB-A34F-CBC6EC8EFCF8Q45068881-7F0863EB-D1BF-437F-9D6C-3728865A1017Q51314899-8F299541-E4FD-4C2B-B93D-35703C55EDC2Q53328385-B489F5F4-97EC-46BC-A3BE-4C06B49E9C3CQ86086562-7E39B475-E724-4F34-9AD9-4C0109FE3AC9
P50
description
academic
@en
name
Karen M Kuntz
@en
type
label
Karen M Kuntz
@en
prefLabel
Karen M Kuntz
@en
P101
P106
P1153
35355556400